SIGMAR1 and amyotrophic lateral sclerosis: For example, it has been shown that SIGMAR1 is able to counteract the physiopathology mechanisms in AD via the BDNF/TrkB pathway [57], and similarly in PD [58], ALS [59], and HD [60].